Stonepine Capital Management »

Boston Scientific Corporation shares owned by Stonepine Capital Management

Quarter-by-quarter ownership of Boston Scientific Corporation (BSX) shares owned by Stonepine Capital Management from 13F filings

Historical chart of Stonepine Capital Management investment in Boston Scientific Corporation

Tip: Access up to 7 years of quarterly data

All positions including Boston Scientific Corporation held by Stonepine Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Boston Scientific Corporation by Stonepine Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $3.3M 50k 65.00

More positions owned by Stonepine Capital Management

Evolus (EOLS)
Verastem Com New (VSTM)
Adma Biologics (ADMA)
Tenax Therapeutics Com New (TENX)
Nektar Therapeutics Com New (NKTR)
Ultragenyx Pharmaceutical (RARE)
Camp4 Therapeutics Corp Com 13469v Ab 4 Camtek Ltd Note 12/0 (CAMP)
Insmed Com Par $.01 Call Option (INSM)
Eloxx Pharmaceuticals Com New
Kazia Therapeutics Sponsored Ads (KZIA)
Medtronic SHS Call Option (MDT)
Indivior Pharmaceuticals (INDV)
Corbus Pharmaceuticals Hldgs Com New (CRBP)
Abbott Laboratories Call Option (ABT)
Satellos Bioscience (MSLE)

View all positions for Stonepine Capital Management

Top funds holding Boston Scientific Corporation

BlackRock
Vanguard Capital Management
State Street Corporation
PRIMECAP Management Company
FMR
Jane Street
Geode Capital Management
Vanguard Portfolio Management
D. E. Shaw & Co
Massachusetts Financial Services
Jpmorgan Chase & Co
Arrowstreet Capital, Limited Partnership
Morgan Stanley
Norges Bank Investment Management
Two Sigma Investments

View all funds holding Boston Scientific Corporation